TI
IRWD icon

Tidal Investments’s Ironwood Pharmaceuticals IRWD Stock Holding History

Tidal Investments’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-304,475
Closed -$1.07M – 2725
2026
Q1 		$1.07M Buy
+304,475
New +$1.25M ﹤0.01% 1445
2025
Q4 		– Sell
-294,236
Closed -$385K – 2236
2025
Q3 		$385K Sell
294,236
-15,843
-5% -$16.4K ﹤0.01% 1716
2025
Q2 		$222K Buy
+310,079
New +$243K ﹤0.01% 1737

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Tidal Investments's IRWD Position: Q2 2026 in Review

Tidal Investments sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2026, closing a stake of 304,475 shares — an estimated $1.07M sold.

Tidal Investments first reported a position in IRWD in Q2 2025 and held it in 3 quarters. The position peaked at $1.07M in Q1 2026. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Tidal Investments reported no remaining Ironwood Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Tidal Investments sold 304,475 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $1.07M.
  • Tidal Investments first reported a position in Ironwood Pharmaceuticals in Q2 2025 and held it in 3 quarters.
  • Tidal Investments's Ironwood Pharmaceuticals position peaked at $1.07M in Q1 2026.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.